Skip to content

Gaia Sampogna

2 papers in the library · 48 citations · publishing 2024-2025

Papers

Sort Most recent Most cited

Emerging strategies and clinical recommendations for the management of novel depression subtypes.

Expert Review of Neurotherapeutics April 1, 2025 Stefania Chiappini, Gaia Sampogna, Antonio Ventriglio et al. 17 citations

The phenomenology of depression is characterized by a wide array of emotional, cognitive, and physical symptoms that significantly disrupt an individual's life. Societal changes, driven by technological advancements, economic pressures, environmental concerns including climate change, and shifting cultural norms, have influenced how depression manifests and is understood. These developments...

Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review.

Frontiers in Psychiatry 2024 Matteo Di Vincenzo, Vassilis Martiadis, Bianca Della Rocca et al. 31 citations

Treatment-resistant depression (TRD) occurs when at least two different antidepressants, taken at the right dosage, for adequate period of time and with continuity, fail to give positive clinical effects. Esketamine, the S-enantiomer of ketamine, was recently approved for TRD treatment from U.S. Food and Drug Administration and European Medicine Agency. Despite proved clinical efficacy, many...